Literature DB >> 29147622

Factors released by the tumor far microenvironment are decisive for pancreatic adenocarcinoma development and progression.

Juan L Iovanna1, Daniel Closa2.   

Abstract

The REG3β protein was identified more than 2 decades ago, but its role in PDAC development was only recently reported. In Pancreatic Ductal Adenocarcinoma (PDAC), REG3β protein is expressed and released by the far microenvironment, which is situated out of the tumor, at the periphery of the tumor mass, and is part of the healthy peri-tumoral region. This compartment is completely unrelated to the classical microenvironment that corresponds to the intra-tumoral stoma. Clinically relevant, the far microenvironment, and the factors released by it, could be novel and original therapeutic targets for treating patients with a PDAC. In this way we recently demonstrated that REG3β is an essential soluble factor necessary for PDAC development which is able to stimulate several simultaneous pro-tumoral mechanisms. We also find that secreted REG3β boosts interactions between epithelial cells and immune cells by activating the CXCL12/CXCR4 signaling cascade, which facilitates tumor escape through evasion of immune surveillance, and promotes metastasis. In addition, REG3β interfere the intercellular communication inside the tumor mediated by extracellular vesicles, resulting in relevant changes in macrophage phenotype or tumor cell migration. Therefore, we are proposing to call as near microenvironment to the classical microenvironment that is constituted by fibroblasts, inflammatory cells and fibers and located into the tumor, and as far microenvironment, which is constituted by the parenchymal non transformed cells located at the periphery of the tumor mass.

Entities:  

Keywords:  Reg3beta; microenvironment; pancreas cancer; pancreatitis; peri-tumoral region

Year:  2017        PMID: 29147622      PMCID: PMC5674953          DOI: 10.1080/2162402X.2017.1358840

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  16 in total

Review 1.  Field effect in cancer-an update.

Authors:  Hong Chai; Robert E Brown
Journal:  Ann Clin Lab Sci       Date:  2009       Impact factor: 1.256

Review 2.  Stromal biology and therapy in pancreatic cancer: a changing paradigm.

Authors:  Albrecht Neesse; Hana Algül; David A Tuveson; Thomas M Gress
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

3.  Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

Authors:  Julie Leca; Sébastien Martinez; Sophie Lac; Jérémy Nigri; Véronique Secq; Marion Rubis; Christian Bressy; Arnauld Sergé; Marie-Noelle Lavaut; Nelson Dusetti; Céline Loncle; Julie Roques; Daniel Pietrasz; Corinne Bousquet; Stéphane Garcia; Samuel Granjeaud; Mehdi Ouaissi; Jean Baptiste Bachet; Christine Brun; Juan L Iovanna; Pascale Zimmermann; Sophie Vasseur; Richard Tomasini
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

4.  Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.

Authors:  Chenjie Zeng; Wanqing Wen; Alicia K Morgans; William Pao; Xiao-Ou Shu; Wei Zheng
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

5.  Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.

Authors:  Qianqian Xu; Rong Fu; Guoxiao Yin; Xiulan Liu; Yang Liu; Ming Xiang
Journal:  Gene       Date:  2015-12-21       Impact factor: 3.688

6.  Characterization of a rat pancreatic secretory protein associated with pancreatitis.

Authors:  V Keim; J L Iovanna; G Rohr; K H Usadel; J C Dagorn
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

7.  Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization.

Authors:  Meritxell Gironella; Carlos Calvo; Anna Fernández; Daniel Closa; Juan L Iovanna; Joan Rosello-Catafau; Emma Folch-Puy
Journal:  Cancer Res       Date:  2013-07-18       Impact factor: 12.701

8.  IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer.

Authors:  Celine Loncle; Laia Bonjoch; Emma Folch-Puy; Maria Belen Lopez-Millan; Sophie Lac; Maria Inés Molejon; Eduardo Chuluyan; Pierre Cordelier; Pierre Dubus; Gwen Lomberk; Raul Urrutia; Daniel Closa; Juan L Iovanna
Journal:  Cancer Res       Date:  2015-09-24       Impact factor: 12.701

9.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

10.  Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.

Authors:  Qing Li; Hao Wang; George Zogopoulos; Qin Shao; Kun Dong; Fudong Lv; Karam Nwilati; Xian-Yong Gui; Adeline Cuggia; Jun-Li Liu; Zu-Hua Gao
Journal:  Oncotarget       Date:  2016-11-22
View more
  6 in total

Review 1.  Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.

Authors:  Elena García-Martínez; Melody Smith; Aitziber Buqué; Fernando Aranda; Francisco Ayala de la Peña; Alejandra Ivars; Manuel Sanchez Cánovas; Ma Angeles Vicente Conesa; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-02-15       Impact factor: 8.110

2.  Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.

Authors:  Chuan-Yuan Wei; Meng-Xuan Zhu; Nan-Hang Lu; Jia-Qi Liu; Yan-Wen Yang; Yong Zhang; Yue-Dong Shi; Zi-Hao Feng; Jia-Xia Li; Fa-Zhi Qi; Jian-Ying Gu
Journal:  Mol Cancer       Date:  2020-05-07       Impact factor: 27.401

3.  Immune profiling and immunotherapeutic targets in pancreatic cancer.

Authors:  Felicia L Lenzo; Shumei Kato; Sarabjot Pabla; Paul DePietro; Mary K Nesline; Jeffrey M Conroy; Blake Burgher; Sean T Glenn; Boris Kuvshinoff; Razelle Kurzrock; Carl Morrison
Journal:  Ann Transl Med       Date:  2021-01

Review 4.  Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review.

Authors:  Huang-Yu Yang; Chao-Yi Wu; Jia-Jin Chen; Tao-Han Lee
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 5.  Cytotoxic and antitumor peptides as novel chemotherapeutics.

Authors:  Xin Luan; Ye Wu; Yi-Wen Shen; Hong Zhang; Yu-Dong Zhou; Hong-Zhuan Chen; Dale G Nagle; Wei-Dong Zhang
Journal:  Nat Prod Rep       Date:  2020-08-10       Impact factor: 15.111

6.  Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.

Authors:  Jian Guo; Huiheng Qu; Ting Shan; Yigang Chen; Ye Chen; Jiazeng Xia
Journal:  Mol Cells       Date:  2018-06-25       Impact factor: 5.034

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.